| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |